NCT00914693

Brief Summary

The aim of the present study is to prove efficacy and safety of a new contraceptive patch.

Trial Health

93
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
1,694

participants targeted

Target at P75+ for phase_3

Timeline
Completed

Started Apr 2009

Geographic Reach
8 countries

66 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 1, 2009

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

May 5, 2009

Completed
1 month until next milestone

First Posted

Study publicly available on registry

June 5, 2009

Completed
2.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2011

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2011

Completed
Last Updated

December 5, 2014

Status Verified

December 1, 2014

Enrollment Period

2.4 years

First QC Date

May 5, 2009

Last Update Submit

December 4, 2014

Conditions

Keywords

Fertility controlContraception

Outcome Measures

Primary Outcomes (1)

  • Occurrence of pregnancy

    13 treatment cycles each consisting of 28 days and follow-up period of 14 days

Secondary Outcomes (3)

  • Cervical smear

    13 treatment cycles each consisting of 28 days

  • Adverse events

    13 treatment cycles each consisting of 28 days

  • Bleeding pattern and cycle control

    13 treatment cycles each consisting of 28 days

Other Outcomes (2)

  • Treatment compliance

    13 treatment cycles each consisting of 28 days

  • Subjective assessment of satisfaction with the treatment

    13 treatment cycles each consisting of 28 days

Study Arms (1)

Arm 1

EXPERIMENTAL
Drug: Ethinylestradiol/Gestodene (BAY86-5016)

Interventions

7-day patch containing 0.55 mg ethinylestradiol (EE) and 2.1 mg gestodene (GSD) in a 21-day regimen

Arm 1

Eligibility Criteria

Age18 Years - 35 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Requiring contraception
  • Normal cervical smear
  • Smokers not older than 30 years
  • History of regular cyclic menstrual periods

You may not qualify if:

  • Pregnancy or lactation
  • Obesity (BMI\> 30 kg/m2
  • Significant skin reaction to transdermal preparations or sensitivity to surgical / medical tape
  • Any disease that may worsen under hormonal treatment (cardiovascular, liver, metabolic)
  • Use of other contraceptive methods than study medication

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (66)

Unknown Facility

Lanús Oeste, Buenos Aires, 1824, Argentina

Location

Unknown Facility

San Isidro, Buenos Aires, B1642CLN, Argentina

Location

Unknown Facility

Buenos Aires, Ciudad Auton. de Buenos Aires, C1280AEB, Argentina

Location

Unknown Facility

Buenos Aires, Ciudad Auton. de Buenos Aires, C1425ASQ, Argentina

Location

Unknown Facility

Buenos Aires, Ciudad Auton. de Buenos Aires, C1425AWC, Argentina

Location

Unknown Facility

Rosario, Santa Fe Province, 2000, Argentina

Location

Unknown Facility

Ashfield, New South Wales, 2031, Australia

Location

Unknown Facility

Adelaide, South Australia, 5000, Australia

Location

Unknown Facility

North Adelaide, South Australia, 5006, Australia

Location

Unknown Facility

Clayton, Victoria, 3168, Australia

Location

Unknown Facility

Nedlands, Western Australia, 6009, Australia

Location

Unknown Facility

Temuco, Región de la Araucanía, 4791348, Chile

Location

Unknown Facility

Santiago, Santiago Metropolitan, 7510025, Chile

Location

Unknown Facility

Santiago, Santiago Metropolitan, 8350488, Chile

Location

Unknown Facility

Santiago, 8320165, Chile

Location

Unknown Facility

Temuco, 4790711, Chile

Location

Unknown Facility

Biarritz, 64200, France

Location

Unknown Facility

Montargis, 45200, France

Location

Unknown Facility

Nîmes, 30029, France

Location

Unknown Facility

Quetigny, 21800, France

Location

Unknown Facility

Reims, 51092, France

Location

Unknown Facility

Saint-Germain-en-Laye, 78100, France

Location

Unknown Facility

Toulouse, 31000, France

Location

Unknown Facility

Frankfurt am Main, Hesse, 60590, Germany

Location

Unknown Facility

Aachen, North Rhine-Westphalia, 52072, Germany

Location

Unknown Facility

Cologne, North Rhine-Westphalia, 50924, Germany

Location

Unknown Facility

Siegen, North Rhine-Westphalia, 57072, Germany

Location

Unknown Facility

Wuppertal, North Rhine-Westphalia, 42103, Germany

Location

Unknown Facility

Dippoldiswalde, Saxony, 01744, Germany

Location

Unknown Facility

Dresden, Saxony, 01099, Germany

Location

Unknown Facility

Leipzig, Saxony, 04207, Germany

Location

Unknown Facility

Leipzig, Saxony, 04299, Germany

Location

Unknown Facility

Blankenburg, Saxony-Anhalt, 38889, Germany

Location

Unknown Facility

Jessen, Saxony-Anhalt, 06917, Germany

Location

Unknown Facility

Magdeburg, Saxony-Anhalt, 39104, Germany

Location

Unknown Facility

Berlin, State of Berlin, 10247, Germany

Location

Unknown Facility

Berlin, State of Berlin, 12587, Germany

Location

Unknown Facility

Berlin, State of Berlin, 13507, Germany

Location

Unknown Facility

Gera, Thuringia, 07545, Germany

Location

Unknown Facility

Francavilla Fontana, Brindisi, 72021, Italy

Location

Unknown Facility

Bologna, 40138, Italy

Location

Unknown Facility

Cagliari, 09124, Italy

Location

Unknown Facility

Catanzaro, 88100, Italy

Location

Unknown Facility

Florence, 50134, Italy

Location

Unknown Facility

Modena, 41124, Italy

Location

Unknown Facility

Palermo, 90127, Italy

Location

Unknown Facility

Pavia, 27100, Italy

Location

Unknown Facility

Perugia, 06156, Italy

Location

Unknown Facility

Pisa, 56126, Italy

Location

Unknown Facility

Siena, 53100, Italy

Location

Unknown Facility

Chihuahua City, Chihuahua, 31350, Mexico

Location

Unknown Facility

Torreón, Coahuila, 27000, Mexico

Location

Unknown Facility

San Luis Potosí City, San Luis Potosí, 78230, Mexico

Location

Unknown Facility

Mexico City, 11000, Mexico

Location

Unknown Facility

México D.F., 10700, Mexico

Location

Unknown Facility

México, D.F., 11000, Mexico

Location

Unknown Facility

Barcelona, Barcelona, 08013, Spain

Location

Unknown Facility

Barcelona, Barcelona, 08028, Spain

Location

Unknown Facility

San Fernando, Cádiz, 11100, Spain

Location

Unknown Facility

Lugo, Lugo, 27002, Spain

Location

Unknown Facility

Pamplona, Pamplona, 31015, Spain

Location

Unknown Facility

Vigo, Pontevedra, 36209, Spain

Location

Unknown Facility

Dos Hermanas, Sevilla, 41700, Spain

Location

Unknown Facility

Alava, Vitoria, 01004, Spain

Location

Unknown Facility

Zaragoza, Zaragoza, 50001, Spain

Location

Unknown Facility

Barcelona, 08035, Spain

Location

Related Links

MeSH Terms

Interventions

Ethinyl EstradiolGestodene

Intervention Hierarchy (Ancestors)

NorpregnatrienesNorpregnanesNorsteroidsSteroidsFused-Ring CompoundsPolycyclic CompoundsEstrogenic Steroids, AlkylatedEstradiol CongenersGonadal Steroid HormonesGonadal HormonesHormonesHormones, Hormone Substitutes, and Hormone Antagonists

Study Officials

  • Bayer Study Director

    Bayer

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
phase 3
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
SINGLE GROUP
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 5, 2009

First Posted

June 5, 2009

Study Start

April 1, 2009

Primary Completion

September 1, 2011

Study Completion

September 1, 2011

Last Updated

December 5, 2014

Record last verified: 2014-12

Locations